Fetal growth retardation, particularly within lymphoid organs, following repeated maternal injections of betamethasone in sheep

Journal of Obstetrics and Gynaecology Research

Volumn 24, Issue 3, 1998, Pages 173-182

  Quinlivan, Julie A ^a   Archer, Michael A ^b   Dunlop, Sarah A ^b   Evans, Sharon F ^b   Beazley, Lyn D ^b   Newnham, John P ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NONE

Author keywords

Corticosteroids; Fetus; Growth; Immunity; Preterm

Indexed keywords

BETAMETHASONE;

ANIMAL EXPERIMENT; ARTICLE; BIOMETRY; CATCH UP GROWTH; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; LIVER; LYMPHOID ORGAN; NONHUMAN; ORGAN WEIGHT; SHEEP; SPLEEN; THYMUS;

EID: 0031926985     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1998.tb00072.x     Document Type: Article

References (37)

1. Liggins G, Howie R. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-525
2. Crowley P. Antenatal corticosteroid therapy: A meta analysis of the randomised trials, 1972-1994. Am J Obstet Gynecol 1995; 173: 322-335
3. MacArthur BA, Howie RN, Dezoete JA, Elkins J. School progress and cognitive development of 6-year old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982; 70: 99-105
4. Collaborative Group on Antenatal Steroid Therapy. Effects of antenatal dexamethasone administration in the infant: Long term follow-up. Pediatrics 1984; 104: 259-267
5. Smolder-de-Haas H, Neuvel J, et al. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: A 10- to 12-year follow up. Pediatrics 1990; 86: 65-70
6. NIH Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995; 273: 413-418
7. de Swiet M. Medical disorders in pregnancy. In Turnbull's Obstetrics. Chamberlain Ed. 2nd edition, Edinburgh: Churchill Livingston, 395
8. Lewis DF, Brody K, Edwards MS, Brouillette RM, Burlson S, London SN. Preterm premature ruptured membranes: A randomised trial of steroids after treatment with antibiotics. Obstet Gynaecol 1996; 88: 810-815
9. Quinlivan JA, Evans SF, Dunlop SA, Beazley LD, Newnham JP. Use of corticosteroids by Australian obstetricians - A survey of clinical practice. Aust NZ J Obstet Gynaecol 1998; 38: 1-7
10. French N, Hagan R, Evans S, Godfrey M, Benninger H, Mullan A, Snowball L, Newnham J. Repeated antenatal corticosteroids: Growth and early childhood outcome. Proc Perinatal Soc Aust NZ, (Abstract) 1997; A12
11. Kelly RW, Newnham JP. Estimation of gestational age in merino ewes by ultrasound measurement of fetal head size. Aust J Agric Res 1989; 40: 1293-1299
12. Howard E. Effects of corticosterone and food restriction on growth and on DNA, RNA, and cholesterol contents of the brain and liver in infant mice. J Neurochem, 1965; 12: 181-191
13. Howard E, Granoff D. Increased voluntary running and decreased motor co-ordination in mice after neonatal corticosterone implantation. Expt Neurol 1968; 22: 661-673
14. Barrada MI, Blomquist CH, Kotts C. The effects of betamethasone on fetal development in the rabbit. Am J Obstet Gynecol 1980; 136: 234- 238
15. Johnson J, Mitzner W, London WT, Palmer AE, Scott R, Kearney K. Glucocorticoids and the rhesus fetal lung. Am J Obstet Gynecol 1978; 130: 905-916
16. Johnson JW, Mitzner W, London WT, Palmer AE, Scott R. Betamethasone and the rhesus fetus: Multisystemic effects. Am J Obstet Gynecol 1979; 133: 677-684
17. Epstein M, Farrell PM, Sparks JW, Pepe G, Driscoll SG, Chez RA. Maternal betamethasone and fetal growth and development in the monkey. Am J Obstet Gynecol 1977; 127 261-263
18. Ballard PL. Antenatal glucocorticoid therapy: Hormone concentrations. In: Ballard PL, ed. Hormones and Lung Maturation. New York: Springer-Verlag, 173-196
19. Johnson J, Mitzner W, Beck JC, London WT, Sly DL, Lee PA, Khouzami VA, Cavalieri RL. Long term effects of betamethasone on fetal development. Am J Obstet Gynecol 1981; 141: 1053-1064
20. Delemos RA. Glucocorticoid effect: Organ development in monkeys, In: Moore TD, ed. Lung Maturation and the Prevention of Hyaline Membrane Disease, Report of the Seventieth Ross Conference on Pediatric Research, Columbus-Ohio: Ross Laboratories, 77
21. Barker DJP, Osmond C, Golding J, Kuh D, Wadsworth MEJ. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298: 576-577
22. Hales CN, Barker DJP, Clark PMS, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303: 1019-1022
23. McCance DR, Pettit DJ, Hanson RL, Jacobsson LTM, Knoowle WC, Bennett PH. Birthweight and non-insulin dependent diabetes: 'thrifty genotype', 'thrifty phenotype', or 'surviving small baby genotype'. BMJ 1994; 308: 942-945
24. Barker DJP. Mothers, Babies, and Disease in Later Life. BMJ Publishing Group, 1994
25. Barker DJP, Martyn CN, Osmond C, Hales CN, Fall CHD. Growth in utero and serum cholesterol concentrations in later life. BMJ 1993; 307: 11524-11527
26. Barker DJP, Meade TW, Fall CHD, et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ 1992; 304: 148-152
27. Romero R. Prenatal medicine: The child is the father of the man. Prenat Neonat Med 1996; 1: 8-11
28. Gurevich P, Czernobilsky B, Ben-Hur H, Nyska A, Zuckerman A, Zusman I. Pathology of lymphoid organs in low birth weight human fetuses subjected to antigen-induced influences: A morphological and morphometric study. Pediatr Pathol 1994; 14: 679-693
29. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-793
30. Karrer U, Althage A, Odermatt B, Roberts CW, Korsmeyer SJ, Miyawaki S, Hengartner H, Zinkernagel RM. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleeenless (Hox11(-)/(-)) mutant mice. J Expt Med 1997; 185: 2157-2170
31. Doherty PC. Anatomical environment as a determinent in viral immunity. J Immunol 1995; 155: 1023-1027
32. Calandra T, Bucala R. Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 1997; 17: 77-88
33. Phillips DI, Cooper C, Fall C, Prentice L, Osmond C, Barker DJ, Rees Smith B. Fetal growth and autoimmune thyroid disease. (Comment in) Quart J Med 1993; 86: 465
34. Godfrey KM, Barker DJ, Osmond C. Disproportionate fetal growth and raised IgE concentration in adult life. (Comment in) Clin Expt Allergy 1994; 24: 641-648
35. Wheeler W, Kurachel S, McNamara J, Fugate I, Hoogenhous N. Consequences of hypogamma-globulinaemia and steroid therapy in severe bronchopulmonary dysplasia. Pediatr Pulmonol 1996; 22: 96-100
36. Biondi M, Zannino LG. Psychological stress, neuroimmunomodulation, and susceptibility to imfectious diseases in animals and man: A review. Psychotherapy Psychosomatics 1997; 66: 3-26
37. Fujii T, Horinaka M, Hata M. Functional effects of glucocorticoid exposure in fetal life. Prog Neuropsychopharm Biol Psychiatry 1993; 17: 279-293